Previous experimental and clinical studies have consistently documented elevated levels of circulating Angiotensin I and Angiotensin II following cholestasis and liver cirrhosis, which have been implicated in the pathogenesis of myocardial fibrosis, ventricular remodeling, and cardiac dysfunction (23-25). This evidence concerns the gene AGT and cholestasis.